TickerFacts.

Hims & Hers Health, Inc. (HIMS): Cost of Revenue

Annual figures by period end, from SEC filings.

$614.26M
Year ended 2025-12-31
$814.03M
Trailing 12 months to 2026-06-30
+73.2%
3-year compound annual growth
+73.3%
5-year compound annual growth
2019-12-31: $37.95M2020-12-31: $39.31M2021-12-31: $67.38M2022-12-31: $118.19M2023-12-31: $157.05M2024-12-31: $303.38M2025-12-31: $614.26M$614.26M
2019-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$614.26M+102.5%2026-02-23, From 2025-01-01
2024-12-31$303.38M+93.2%2026-02-23, From 2024-01-01
2023-12-31$157.05M+32.9%2026-02-23, From 2023-01-01
2022-12-31$118.19M+75.4%2025-02-24, From 2022-01-01
2021-12-31$67.38M+71.4%2024-02-26, From 2021-01-01
2020-12-31$39.31M+3.6%2023-02-27, From 2020-01-01
2019-12-31$37.95Mn/a2022-02-24, From 2019-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Offices & Clinics of Doctors of Medicine), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Hims & Hers Health, Inc. (HIMS)2025-12-31$614.26M+102.5%
LifeMD, Inc. (LFMD)2025-12-31$27.71M+29.3%
SBC Medical Group Holdings Inc (SBC)2025-12-31$46.32M-6.2%
Cardiff Lexington Corp (CDIX)2025-12-31$4.33M+12.7%

Compare HIMS, LFMD, SBC, CDIX side by side · Screen every company in Services-Offices & Clinics of Doctors of Medicine ↗